604 related articles for article (PubMed ID: 15698589)
1. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
Murayama T; Taguchi H
Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
4. [Studies of urinary risk factors in urolithiasis].
Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
Murayama T; Taguchi H
Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
[TBL] [Abstract][Full Text] [Related]
6. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
7. [Hyperuricosuria and urolithiasis].
Koide T
Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
[TBL] [Abstract][Full Text] [Related]
8. The hyperuricosuric calcium oxalate stone former.
Sarig S
Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
[TBL] [Abstract][Full Text] [Related]
9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
10. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
Alvarez Arroyo MV; Traba ML; Rapado A
Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary composition of calcium oxalate stone formers.
Rahman B; Rahman MA
Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
[TBL] [Abstract][Full Text] [Related]
12. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
15. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
[TBL] [Abstract][Full Text] [Related]
16. The most important metabolic risk factors in recurrent urinary stone formers.
Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
[TBL] [Abstract][Full Text] [Related]
17. Local factors compared with systemic factors in the formation of bladder uric acid stones.
Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
[TBL] [Abstract][Full Text] [Related]
18. Effect of cranberry juice consumption on urinary stone risk factors.
Gettman MT; Ogan K; Brinkley LJ; Adams-Huet B; Pak CY; Pearle MS
J Urol; 2005 Aug; 174(2):590-4; quiz 801. PubMed ID: 16006907
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]